Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

Munir Pirmohamed, Sally James, Shaun Meakin et al. · BMJ · 2004 · 3.2K citations · Full text

Pharmacology and Management of the Vitamin K Antagonists

Jack Ansell, Jack Hirsh, Elaine M. Hylek et al. · CHEST Journal · 2008 · 2.1K citations

Vitamin K Antagonists, Pharmacological Study, Pharmacology +5

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

Gualtiero Palareti, Nicoletta Leali, S Coccheri et al. · The Lancet · 1996 · 1.3K citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +14

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

Fumihiko Takeuchi, Ralph McGinnis, Stéphane Bourgeois et al. · PLoS Genetics · 2009 · 635 citations · Full text

Genome-wide Association Study, Thrombosis, Therapeutic Warfarin Dose +15

CYP4F2 genetic variant alters required warfarin dose

Michael D. Caldwell, Tarif Awad, Julie A. Johnson et al. · Blood · 2008 · 519 citations · Full text